510(k) Report

FDA product code · Neurology

Cranial Electrotherapy Stimulator To Treat Depression

JXKClass III21 CFR 882.5800PMA required2 decisions since 20253 recalls

2 FDA decisions since 2025. 3 recalls name this code, 0 of them Class I.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026 Download the data (CSV)

FIG. A — Illustration, neurology panel

Twenty years of JXK at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.

FDA decisions per year · JXK

2in 2025

2025: 22026 (partial year): 1
2007high 2 (2025) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JXK

Too few JXK 510(k)s in any year since 2007 to give a median.

Recalls per year · JXK

2in 2007

2007: 2
2007high 2 (2007) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JXK

1in 2020

2007: 22009: 12010: 12011: 12012: 12013: 32014: 12015: 42016: 12020: 1
2007high 4 (2015) · low 0 (2008)2025

MAUDE reports naming product code JXK, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—22
20080—00
20090—01
20100—01
20110—01
20120—01
20130—03
20140—01
20150—04
20160—01
20170—00
20180—00
20190—00
20200—01
20210—00
20220—00
20230—00
20240—00
20252—00
20261—0—
FIG. 1 — JXK by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports, MAUDE · Data through Oct 25, 2026

Planning a device in JXK? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Related product codes

Other codes under 21 CFR 882.5800.